We are live on ! Find out more
FBIO icon

Fortress Biotech

62 hedge funds and large institutions have $24.4M invested in Fortress Biotech in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

7% more funds holding

Funds holding: 5862 (+4)

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

0.01% less ownership

Funds ownership: 0.81%0.79% (-0.01%)

10% less capital invested

Capital invested by funds: $27M → $24.4M (-$2.61M)

Holders
62
Holders Change
+4
Holders Change %
+6.9%
% of All Funds
1.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
17
Reduced
16
Closed
7
Calls
$18K
Puts
Net Calls
+$18K
Net Calls Change
-$114K

FBIO Hedge Fund Activity: Q4 2017 in Review

62 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2017, worth a combined $24.4M — down 9.7% from $27M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new FBIO positions and 7 closed out — a net gain of 4 holders — while 17 added to existing stakes and 16 trimmed.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $217K. The largest seller was Millennium Management, cutting an estimated $369K.

  • 62 institutional investors held Fortress Biotech (FBIO) as of Q4 2017, up from 58 in Q3 2017.
  • Funds reported $24.4M of Fortress Biotech stock for Q4 2017, down 9.7% quarter-over-quarter.
  • 11 funds opened new Fortress Biotech positions in Q4 2017 and 7 closed out, a net change of +4 holders.
  • The largest Fortress Biotech buyer in Q4 2017 was Jacobs Levy Equity Management, an estimated $217K added.
  • The largest Fortress Biotech seller in Q4 2017 was Millennium Management, an estimated $369K sold.

Based on aggregated 13F filings for Q4 2017.